Results 61 to 70 of about 16,198,215 (212)

Impact of opioid use disorder as a safety risk in elective total hip arthroplasty: an imperative for routine preoperative screening

Patient Safety in Surgery
Background Total hip arthroplasty (THA) utilization is rising worldwide, but the concurrent opioid epidemic has introduced new perioperative safety challenges.
David Maman, Yaniv Steinfeld, Yaron Berkovich   +2 more
doaj   +1 more source

Demographic and Mental Health Characteristics of Individuals Who Present to Community Health Clinics With Substance Misuse

Health Services Research & Managerial Epidemiology, 2017
Introduction: Community health clinics (CHCs) are an opportune setting to identify and treat substance misuse. This study assessed the characteristics of patients who presented to a CHC with substance misuse.
Praise O. Iyiewuare, Colleen McCullough, Allison Ober, Kirsten Becker, Karen Osilla, Katherine E. Watkins   +5 more
doaj   +1 more source

Joint associations of recovery capital and polygenic risk with electronic health record observed remission and relapse in substance use disorder: Longitudinal evidence from the All of Us research program

Addiction, EarlyView.
Abstract Background and aims Recovery capital and genetic liability may be related to substance use disorder (SUD) remission through psychosocial and biologic pathways, but their joint association with remission course remains poorly understood. This question is clinically important because people entering remission differ in recovery resources and ...
Janaka V. Kosgolla, Douglas C. Smith
wiley   +1 more source

Chronic pain treatment experiences and barriers among opioid agonist treatment participants who inject drugs: A qualitative study

Addiction, EarlyView.
Abstract Background and aim Co‐occurring chronic pain affects nearly half of people receiving opioid use disorder (OUD) treatment. Although this pain is often severe, it is usually inadequately managed. Stigma and clinical complexity associated with OUD are thought to further restrict access to pain care.
Jie Yang, Shelley Walker, Amy G. McNeilage, Peter Higgs, Louisa Picco, Paul Dietze, Suzanne Nielsen   +6 more
wiley   +1 more source

Opioids for Pain Treatment in Persons with Opioid Use Disorder

, 2021
This presentation will review safe and effective pain treatment, how to support recovery from opioid use disorder and avoid relapse in patients with OUD, and how to avoid personal and public health consequences of opioid use disorder.
Weimer, Melissa
core   +1 more source

Variation in 90‐day substance use disorder‐related acute care events across United States opioid treatment programs: A Medicaid claims analysis

Addiction, EarlyView.
Abstract Background and aims Creating and tracking quality measures has improved outcomes in many areas of healthcare; however, quality measures specific to opioid treatment programs (OTPs) have not yet been developed. Based on the success seen in other fields, introducing quality measures in OTPs should help enhance positive outcomes and decrease ...
Barrett Wallace Montgomery, Tami L. Mark, Thanh Lu, William N. Dowd, Dylan DeLisle, Kathryn N. Burke, Daniel H. Barch, Gary A. Zarkin   +7 more
wiley   +1 more source

Clinical features of mental imagery in substance use disorders: A mixed‐methods analysis

Addiction, EarlyView.
Abstract Aims To characterise the frequency, features and content of craving‐related mental imagery among people seeking treatment for substance use disorders (SUDs); examine within‐session change in self‐reported craving following imagery elicitation; and explore perceived links with autobiographical memory, behavioural, cognitive and emotional ...
Gemma Scott, Tim Meynen, Francesca Small, Luke Mitcheson, Elizabeth Appiah‐Kusi, William Barber, Colette Hirsch, John Marsden   +7 more
wiley   +1 more source

Buprenorphine/naloxone initiation in the emergency department: A series of vignettes

JEM Reports
Background: Opioid drug overdose deaths are at an all-time high. Buprenorphine, a medication used to treat opioid use disorder, has dramatic effects on mortality after overdose as well as engagement with outpatient treatment programs.
Margarita Popova, Karen Chung, Sumitha Raman, Sonal Batra, Damali Nakitende, Keith Boniface   +5 more
doaj   +1 more source

Profiling neuronal methylome and hydroxymethylome of opioid use disorder in the human orbitofrontal cortex

Nature Communications, 2023
Opioid use disorder (OUD) is influenced by genetic and environmental factors. While recent research suggests epigenetic disturbances in OUD, this is mostly limited to DNA methylation (5mC). DNA hydroxymethylation (5hmC) has been widely understudied.
Gregory Rompala, Sheila T. Nagamatsu, José Jaime Martínez-Magaña, Diana L. Nuñez-Ríos, Jiawei Wang, Matthew J. Girgenti, John H. Krystal, Joel Gelernter, Traumatic Stress Brain Research Group, Yasmin L. Hurd, Janitza L. Montalvo-Ortiz   +10 more
doaj   +1 more source

Reasonable Exceptions From Unreasonable Policies: Requiring Treatment Agreements for Long‐Term Opioid Therapy and Exemptions for Cancer and Terminal Illness

Bioethics, EarlyView.
ABSTRACT Since drug overdose deaths began increasing in the United States, policy makers and the medical community have developed tools to try to address the crisis. Opioid Treatment Agreements (OTAs) are one such tool which purportedly seek to promote shared decision‐making and informed consent with patients. OTAs are documents that clinicians present
Larisa Svirsky, Martin Fried, Minseo Kim, Sarah R. MacEwan, Nathan Richards, Patricia Zettler, Dana Howard   +6 more
wiley   +1 more source